Medicine
Ryaltris 25 mcg/665 mcg nasal spray
Ryaltris 25 mcg/665 mcg nasal spray is a prescription medicine containing Mometasone furoate and Olopatadine for nasal use, marketed by Glenmark Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not store in a freezer or refrigerator. Store RYALTRIS upright with the…
Key facts
- Active ingredient (INN)
- Mometasone furoate and Olopatadine
- Brand
- Ryaltris
- Strength
- 25 mcg/665 mcg
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 12 cartons and 1 more
- Marketing authorisation holder
- Glenmark Pharmaceuticals
- Manufacturers
- Glenmark PharmaceuticalsIndiaHikma Specialty
- Origin register
- US FDA, United States
- Storage
- Do not store in a freezer or refrigerator. Store RYALTRIS upright with the purple dust cap on at room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 August 2022
- Identifiers
- RxCUI 2591806, 2591812DailyMed set ID 406be932-f00e-4c66-9dd1-c142090fe822, 382eac74-a7ce-4f42-ac0a-b253308f335fNDC 68462-659, 59467-700Application NDA211746
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 carton in 1 box / 1 bottle, spray in 1 carton / 240 spray, metered in 1 bottle, spray | 68462-659-27 | Glenmark PharmaceuticalsIndia | 13 January 2026 |
| 12 carton in 1 box / 1 bottle, spray in 1 carton / 56 spray, metered in 1 bottle, spray | 68462-659-84 | Glenmark PharmaceuticalsIndia | 13 January 2026 |
| 12 carton in 1 box / 1 bottle, spray in 1 carton / 240 spray, metered in 1 bottle, spray | 59467-700-27 | Hikma Specialty | 15 August 2022 |
| 12 carton in 1 box / 1 bottle, spray in 1 carton / 56 spray, metered in 1 bottle, spray | 59467-700-84 | Hikma Specialty | 15 August 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 January 2022 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Mometasone furoate and Olopatadine is a fixed-dose combination of a corticosteroid, a histamine-1 receptor antagonist and a histamine-1 receptor inhibitor. It is available as nasal spray. MedsAcross supplies Mometasone furoate and Olopatadine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Mometasone furoate and OlopatadineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ryaltris prescribing information (Glenmark Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ryaltris 25 mcg/665 mcg nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.